S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden's Plan to Confiscate Your Cash? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden's Plan to Confiscate Your Cash? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden's Plan to Confiscate Your Cash? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden's Plan to Confiscate Your Cash? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
MUST WATCH: Unusual 3-second financial maneuver (Ad)
NASDAQ:TCON

TRACON Pharmaceuticals - TCON Insider Trading & Ownership

$1.88
-0.02 (-1.05%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.85
$1.93
50-Day Range
$1.30
$2.02
52-Week Range
$1.24
$4.49
Volume
12,658 shs
Average Volume
97,513 shs
Market Capitalization
$38.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.09%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$2.32 M
Number Of
Insiders Selling
(Last 12 Months)
0

TCON Insider Buying and Selling by Quarter

Get TCON Insider Trade Alerts

Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


TRACON Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2022Opaleye Management Inc.Major ShareholderBuy2,254$1.72$3,876.88370,000  
7/22/2022Charles TheuerCEOBuy4,500$1.85$8,325.00262,518  
7/14/2022Opaleye Management Inc.Major ShareholderBuy7,187$1.81$13,008.47355,920  
7/12/2022Charles TheuerCEOBuy3,000$1.87$5,610.00255,018  
6/24/2022Opaleye Management Inc.Major ShareholderBuy11,419$1.39$15,872.41348,733  
6/21/2022Opaleye Management Inc.Major ShareholderBuy841,989$1.31$1,103,005.593,776,589  
5/10/2022Opaleye Management Inc.Major ShareholderBuy9,700$1.76$17,072.002,934,600  
5/9/2022Charles TheuerCEOBuy10,000$1.85$18,500.00252,018  
5/6/2022Charles TheuerCEOBuy2,500$1.97$4,925.00242,018  
4/29/2022Charles TheuerCEOBuy5,000$1.97$9,850.00239,518  
4/25/2022Opaleye Management Inc.Major ShareholderBuy10,777$2.18$23,493.862,920,000  
4/22/2022Opaleye Management Inc.Major ShareholderBuy42,000$2.24$94,080.002,910,000  
4/21/2022Charles TheuerCEOBuy4,500$2.30$10,350.00234,518  
4/13/2022Opaleye Management Inc.Major ShareholderBuy7,345$2.50$18,362.502,862,296  
4/11/2022Opaleye Management Inc.Major ShareholderBuy9,100$2.42$22,022.002,844,198  
4/8/2022Charles TheuerCEOBuy2,000$2.50$5,000.00226,518  
3/30/2022Charles TheuerCEOBuy4,000$2.70$10,800.00  
3/29/2022Scott B BrownCFOBuy1,000$2.82$2,820.00  
3/21/2022Charles TheuerCEOBuy1,200$2.45$2,940.00  
1/28/2022Opaleye Management Inc.Major ShareholderBuy500$2.20$1,100.00  
1/24/2022Opaleye Management Inc.Major ShareholderBuy17,363$2.05$35,594.15  
1/21/2022Opaleye Management Inc.Major ShareholderBuy35,000$2.19$76,650.00  
1/19/2022Opaleye Management Inc.Major ShareholderBuy23,688$2.24$53,061.12  
12/29/2021Opaleye Management Inc.Major ShareholderBuy52,325$2.51$131,335.75  
12/27/2021Opaleye Management Inc.Major ShareholderBuy87,325$2.92$254,989.00  
12/15/2021Opaleye Management Inc.Major ShareholderBuy21,964$2.43$53,372.52  
12/13/2021Opaleye Management Inc.Major ShareholderBuy15,204$2.64$40,138.56  
12/6/2021Opaleye Management Inc.Major ShareholderBuy22,733$2.26$51,376.58  
12/3/2021Opaleye Management Inc.Major ShareholderBuy89,274$2.30$205,330.20  
11/18/2021Charles TheuerCEOBuy681$2.88$1,961.28  
11/5/2021Charles TheuerCEOBuy4,000$3.41$13,640.00  
8/16/2021Charles TheuerCEOBuy3,000$3.56$10,680.00  
7/26/2021Saundra L PelletierDirectorBuy6,545$3.82$25,001.90  
3/8/2021Scott B. BrownCFOBuy1,000$8.30$8,300.00  
1/27/2021Charles TheuerCEOBuy11,000$8.98$98,780.00201,232  
12/30/2020Ikarian Capital, LlcMajor ShareholderBuy520,291$9.61$4,999,996.51  
12/29/2020Mark C. WigginsinsiderBuy1,000$10.57$10,570.00190,232  
12/22/2020Opaleye Management Inc.Major ShareholderBuy496,277$8.06$3,999,992.62  
10/21/2020Charles TheuerCEOBuy2,000$4.38$8,760.00  
10/21/2020Opaleye Management Inc.Major ShareholderBuy8,656$4.40$38,086.40  
9/23/2020Charles TheuerCEOBuy5,000$4.72$23,600.00186,775  
9/23/2020Opaleye Management Inc.Major ShareholderBuy57,200$4.83$276,276.00  
9/11/2020Ikarian Capital, LlcMajor ShareholderBuy78,201$3.93$307,329.93  
9/10/2020Mark C. WigginsInsiderBuy7,000$4.14$28,980.00  
9/9/2020Opaleye Management Inc.Major ShareholderBuy47,500$3.47$164,825.00  
9/4/2020Charles TheuerCEOBuy10,000$2.58$25,800.00176,882  
9/4/2020Opaleye Management Inc.Major ShareholderBuy9,058$2.88$26,087.04  
9/2/2020Opaleye Management Inc.Major ShareholderBuy119,800$2.35$281,530.00  
8/31/2020Opaleye Management Inc.Major ShareholderBuy302,150$1.76$531,784.00  
8/27/2020Opaleye Management Inc.Major ShareholderBuy183,354$1.71$313,535.34  
8/20/2020Charles TheuerCEOBuy30,000$1.58$47,400.00166,557  
8/18/2020Charles TheuerCEOBuy44,743$1.63$72,931.0991,814  
8/14/2020Charles TheuerCEOBuy100$1.70$170.0091,814  
8/12/2020Charles TheuerCEOBuy15,000$1.75$26,250.0076,714  
6/24/2020Charles TheuerCEOBuy9,895$1.90$18,800.5071,714  
6/15/2020Saundra L PelletierDirectorBuy3,000$2.07$6,210.002,500  
6/11/2020Saundra L PelletierDirectorBuy2,500$2.00$5,000.002,500  
5/22/2020Charles TheuerCEOBuy10,592$2.08$22,031.36  
3/12/2020Charles TheuerCEOBuy10,000$1.18$11,800.0031,777  
3/10/2020Charles TheuerCEOBuy10,000$1.87$18,700.0026,777  
1/23/2020Mark C WigginsInsiderBuy5,000$4.02$20,100.005,000  
8/9/2019Charles TheuerInsiderBuy50,000$0.45$22,500.00173,565  
12/21/2018Charles TheuerCEOBuy49,000$0.66$32,340.00  
11/29/2018Cross-Border Opportu PuissanceMajor ShareholderBuy4,326$1.13$4,888.38  
3/27/2018Enterprise Associates 14 NewMajor ShareholderBuy707,964$2.70$1,911,502.80  
6/2/2017William R LarueDirectorSell2,500$2.69$6,725.0013,388  
11/29/2016Peter W SonsiniMajor ShareholderBuy869,565$5.75$4,999,998.75  
6/3/2016Ronald L ShazerInsiderSell1,003$7.48$7,502.44335  
10/16/2015Jafco Super V3 Investment LimiMajor ShareholderSell1,500$9.90$14,850.001,497,053  
10/15/2015Jafco Super V3 Investment LimiMajor ShareholderSell5,300$10.16$53,848.001,498,553  
10/13/2015Jafco Super V3 Investment Limimajor shareholderSell3,168$10.01$31,711.681,503,853  
10/9/2015Jafco Super V3 Investment Limimajor shareholderSell1,448$10.01$14,494.481,503,853  
10/8/2015Jafco Super V3 Investment Limimajor shareholderSell21,920$10.10$221,392.001,507,021  
10/5/2015Jafco Super V3 Investment Limimajor shareholderSell15,100$10.08$152,208.001,528,941  
9/25/2015Jafco Super V3 Investment LimiMajor ShareholderSell7,600$12.13$92,188.001,544,041  
9/24/2015Jafco Super V3 Investment Limimajor shareholderSell22,303$12.99$289,715.971,551,641  
9/22/2015Jafco Super V3 Investment Limimajor shareholderSell39,426$14.02$552,752.521,573,944  
9/21/2015Jafco Super V3 Investment Limimajor shareholderSell18,200$14.48$263,536.001,573,944  
9/18/2015Charles TheuerCEOSell10,000$17.34$173,400.00  
9/18/2015H Casey LoganinsiderSell5,000$17.34$86,700.00  
9/17/2015Jafco Super V3 Investment Limimajor shareholderSell42,344$11.78$498,812.321,613,370  
9/14/2015Jafco Super V3 Investment Limimajor shareholderSell60,038$11.78$707,247.641,655,714  
9/10/2015Charles TheuerCEOSell3,516$12.00$42,192.00  
9/9/2015Jafco Super V3 Investment Limimajor shareholderSell12,000$10.71$128,520.001,715,752  
9/8/2015Jafco Super V3 Investment Limimajor shareholderSell5,700$10.47$59,679.001,715,752  
9/4/2015Jafco Super V3 Investment Limimajor shareholderSell6,600$10.48$69,168.001,715,752  
9/3/2015Jafco Super V3 Investment Limimajor shareholderSell15,300$10.51$160,803.001,740,052  
9/1/2015Jafco Super V3 Investment Limimajor shareholderSell14,000$10.42$145,880.001,755,352  
8/24/2015Jafco Super V3 Investment LimiMajor ShareholderSell3,000$11.00$33,000.001,769,352  
8/20/2015Jafco Super V3 Investment Limimajor shareholderSell10,683$11.36$121,358.881,772,352  
8/18/2015Jafco Super V3 Investment LimiMajor ShareholderSell11,174$11.71$130,847.54  
8/13/2015Jafco Super V3 Investment LimiMajor ShareholderSell9,361$11.60$108,587.60  
2/4/2015M James BarrettMajor ShareholderBuy500,000$10.00$5,000,000.00  
(Data available from 1/1/2013 forward)












TCON Insider Trading Activity - Frequently Asked Questions

Who is on TRACON Pharmaceuticals's Insider Roster?

The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Ikarian Capital, Llc, Mark C Wiggins, Opaleye Management Inc., Saundra L Pelletier, Scott B Brown. Learn more on insiders at TCON.

What percentage of TRACON Pharmaceuticals stock is owned by insiders?

3.09% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings.

Which TRACON Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased TCON shares in the last 24 months: Charles Theuer ($406,272.37), Ikarian Capital, Llc ($5,307,326.44), Mark C. Wiggins ($39,550.00), Opaleye Management Inc. ($7,845,857.99), Saundra L Pelletier ($25,001.90), and Scott B Brown ($2,820.00).

How much insider buying is happening at TRACON Pharmaceuticals?

Insiders have purchased a total of 3,308,403 TCON shares in the last 24 months for a total of $13,635,128.70 bought.

This page (NASDAQ:TCON) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.